ArticleCancer immunology, immunotherapy : CII2025

Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy.

Yuanshan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.